Nusrat Jahan, MD

Nusrat Jahan, MD, is an assistant professor of medicine – hematology & oncology at the O’Neal Comprehensive Cancer Center at The University of Alabama at Birmingham.

Articles by Nusrat Jahan, MD

Dr Jahan on the Role of T-DXd in HR+/HER2-Low Metastatic Breast Cancer

ByNusrat Jahan, MD

May 12th 2025

Nusrat Jahan, MD, explains the role of T-DXd as the first cytotoxic therapy in patients with HR-positive/HER2-low or -ultralow breast cancer.

Nusrat Jahan, MD

Articles by Nusrat Jahan, MD

Dr Jahan on the Role of T-DXd in HR+/HER2-Low Metastatic Breast Cancer

Latest Updated Articles

Trending on OncLive

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies